Browsing by Author De Deurwaerdere, Philippe

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 15 of 15
Issue DateTitleAuthor(s)
2015The 5-HT4 agonist prucalopride stimulates L-DOPA-induced dopamine release in restricted brain regions of the hemiparkinsonian rat in vivoNavailles, Sylvia; Di Giovanni, Giuseppe; De Deurwaerdere, Philippe
2017Expanding the repertoire of L-DOPA’s actions : a comprehensive review of its functional neurochemistryDe Deurwaerdere, Philippe; Di Giovanni, Giuseppe; Millan, Mark J.
2014Meeting report : Neuropathology and Neuropharmacology of Monoaminergic systemsRamsay, Rona R.; De Deurwaerdere, Philippe
2016Monoaminergic and histaminergic strategies and treatments in brain diseasesDi Giovanni, Giuseppe; Svob Strac, Dubravka; Sole, Montse; Unzeta, Mercedes; Tipton, Keith F.; Muck-Seler, Dorotea; Bolea, Irene; Della Corte, Laura; Nikolac Perkovic, Matea; Pivac, Nela; Smolders, Ilse J.; Stasiak, Anna; Fogel, Wieslawa A.; De Deurwaerdere, Philippe
2016Monoaminergic mechanisms in epilepsy may offer innovative therapeutic opportunity for monoaminergic multi-target drugsSvob Strac, Dubravka; Pivac, Nela; Smolders, Ilse J.; Fogel, Wieslawa A.; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe
2014N-(furan-2-ylmethyl)-N-methylprop-2-yn-1-amine (F2MPA) : a potential cognitive enhancer with MAO inhibitor propertiesDi Giovanni, Giuseppe; Garcia, Isela; Colangeli, Roberto; Pierucci, Massimo; Rivadulla, Marcos L.; Soriano, Elena; Chioua, Mourand; Della Corte, Laura; Yanez, Matilde; De Deurwaerdere, Philippe; Fall, Yagamare; Marco-Contelles, Jose
2017Neurobiology and neuropharmacology of monoaminergic systemsDe Deurwaerdere, Philippe; Ramsay, Rona R.; Di Giovanni, Giuseppe
2016New therapeutic opportunities for 5-HT2C receptor ligands in neuropsychiatric disordersDi Giovanni, Giuseppe; De Deurwaerdere, Philippe
2014Noradrenergic terminals regulate l-DOPA-derived dopamine extracellular levels in a region-dependent manner in Parkinsonian ratsNavailles, Sylvia; Milan, Lea; Khalki, Hanane; Di Giovanni, Giuseppe; Lagiere, Melanie; De Deurwaerdere, Philippe
2014Predicting dopaminergic effects of L-DOPA in the treatment for Parkinson's diseaseNavailles, Sylvia; Di Giovanni, Giuseppe; De Deurwaerdere, Philippe
2014Role of central serotonin receptors in nicotine addictionPierucci, Massimo; Chambers, Stephanie; Partridge, Lucy; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe
2014Role(s) of the 5-HT2C receptor in the development of maximal dentate activation in the hippocampus of anesthetized ratsOrban, Gergely; Bombardi, Cristiano; Marino Gammazza, Antonella; Colangeli, Roberto; Pierucci, Massimo; Pomara, Cristoforo; Pessia, Mauro; Bucchieri, Fabio; Arcangelo, Benigno; Smolders, Ilse J.; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe
2015Serotonergic modulation of the activity of mesencephalic dopaminergic systems : therapeutic implicationsDe Deurwaerdere, Philippe; Di Giovanni, Giuseppe
2017TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7- yl]methanamine] : a hallucinogenic drug, a selective 5-HT2A receptor pharmacological tool, or none of the above?Di Giovanni, Giuseppe; De Deurwaerdere, Philippe
2016Updating neuropathology and neuropharmacology of monoaminergic systemsRamsay, Rona R.; De Deurwaerdere, Philippe; Di Giovanni, Giuseppe